Task: Answer the multiple-choice question.
Query: Which drug exhibits a -8.990% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COC(CNC(=O)c1ccc2c(c1)nc(C)n2-c1cccc(F)c1)OC
b) O=C(N/N=C/c1c(O)ccc2ccccc12)c1cccc(C(F)(F)F)c1
c) O=C(Nc1ccccc1F)C1CCCN(S(=O)(=O)c2ccccc2)C1
Answer: a. COC(CNC(=O)c1ccc2c(c1)nc(C)n2-c1cccc(F)c1)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(CNC(=O)c1ccc2c(c1)nc(C)n2-c1cccc(F)c1)OC
COC(CNC(=O)c1ccc2c(c1)nc(C)n2-c1cccc(F)c1)OC
N-(2,2-dimethoxyethyl)-1-(3-fluorophenyl)-2-methylbenzimidazole-5-carboxamide